Could a tiny nerve stimulator ease chronic pain without drugs?
NCT ID NCT06741579
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 28 times
Summary
This Stanford-led study tests whether adding a peripheral nerve stimulation (PNS) device to standard medical care can reduce chronic neuropathic pain in the lower back, pelvis, or legs. About 148 adults with long-term nerve pain will be randomly assigned to either standard care alone or standard care plus a wearable PNS device that sends electrical pulses to the nerve. The main goal is to see if more people in the device group achieve at least 50% pain relief after 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC NEUROPATHIC PAIN IN THE LOW BACK AND LEGS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Stanford University
RECRUITINGPalo Alto, California, 94304, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Peripheral nerve stimulation device (SPR SPRINT PNS System)
What this could lead to
If successful, this could provide a non-drug option for people with chronic neuropathic pain to achieve significant pain relief.
What could go wrong
This is a mid-stage trial with 148 participants, so results may not apply to everyone. The device requires daily use and may not work for all types of pain.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.